New Guidance on Using Diabetes Technologies

Clinical Takeaway

: A new AACE consensus statement offers practical guidance on when and how to use advanced diabetes technologies.

An overview of the 2026 American Association of Clinical Endocrinology Consensus Statement: Use of Diabetes Technology for Management of Adults with Diabetes

Background

The American Diabetes Association recently recommended earlier and broader use of diabetes technologies, including continuous glucose monitoring (CGM) devices, automated insulin delivery (AID) systems, and smart insulin pens and patches. But rapid advances have made it challenging for clinicians to choose among these technologies and incorporate them into practice. A new consensus statement from the American Association of Clinical Endocrinology (AACE) provides practical guidance.

Key Points

CGM devices

There is a strong evidence base for using CGM in insulin-requiring patients (…

Reviewing Author

Ole-Petter R. Hamnvik, M.B. B.Ch. B.A.O., M.M.Sc., M.R.C.P.I.

Disclosures

Editorial BoardsEndocrine Practice

Leadership Roles in Professional SocietiesAssociation of Program Directors in Endocrinology and Metabolism (Secretary-Treasurer); World Professional Association for Transgender Health (Cochair, Curriculum Development Committee)